GSK turns around
Source: AP |
00:01 UTC+8 July 26, 2018
|
Print Edition
Print Edition
Drug maker GlaxoSmithKline says second-quarter revenue was 7.3 billion pounds (US$9.6 billion), up 4 percent when discounting currency shifts, amid a promising performance of a new shingles treatment. Sales of the shingles treatment Shingrix made 167 million pounds, and the company increased its forecast for 2018 sales of the drug to as much as 650 million pounds. GlaxoSmithKline yesterday reported second-quarter net income of 441 million pounds after posting a loss of 180 million pounds in the same period last year.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
